GERD News

• COVID Raises Risk for Long-Term GI Complications Overall, patients infected with the virus had a 36% higher risk of developing GI conditions.
  Medscape Medical News, March 13, 2023
• EoE: One-Food Elimination Works as Well as Six-Food Elimination Eliminating only milk not only reduced symptoms but also improved quality of life for patients with eosinophilic esophagitis.
  Medscape Medical News, March 06, 2023
• Indian Court Orders Jail for 2 Maiden Executives for Shoddy Drugs A court has sentenced two pharma executives to jail for exporting substandard drugs to Vietnam a decade ago, after the WHO linked their cough syrups to the deaths of children in Gambia.
  Reuters Health Information, February 28, 2023
• AAAAI 2023 New Data Strengthen Case for Oral Immunotherapy in Tots Real-world data from food-allergic toddlers add to prior studies suggesting that oral immunotherapy is safer and more effective at very young ages.
  Medscape Medical News, February 28, 2023
• First Zantac Cancer Risk Trial in California Postponed by Months The first scheduled trial over claims that GSK's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed, likely by several months.
  Reuters Health Information, February 27, 2023
• Judge Weighs Key Evidence Ahead of First Zantac Cancer Trial Lawyers for a man who alleges he developed bladder cancer after taking heartburn drug Zantac urged a California judge on Thursday to allow expert testimony at an upcoming trial.
  Reuters Health Information, February 17, 2023
• FDA Puts Hold on Esophagitis, H pylori Drug The regulatory delays stem from the presence of trace levels of a nitrosamine impurity that were initially detected in launch materials for two vonoprazan products from Phathom Pharmaceuticals.
  Medscape Medical News, February 15, 2023
• Gastroparesis Referrals Often Based on Misdiagnosis About 80% of patients referred to tertiary care with suspected gastroparesis have another gastrointestinal condition, find US researchers. They emphasize the need for guideline-led assessments.
  Medscape Medical News, February 14, 2023
• Antidepressants Mostly Ineffective, 'Lackluster' for Chronic Pain In a new analysis of 26 systematic reviews, most comparisons had inconclusive evidence of the effectiveness of antidepressants compared with placebo in treating pain.
  Medscape Medical News, February 02, 2023
• Sanofi and Regeneron's Dupixent Wins New European Commission Approval Sanofi and Regeneron said on Monday that their Dupixent product had won approval from the European Commission to treat eosinophilic esophagitis.
  Reuters Health Information, January 30, 2023
• Spanish Consensus Document on Severe Adult Asthma Updated Severe asthma requires a multidisciplinary approach that involves treatment with multiple drugs at high doses, according to pulmonologists.
  Medscape Medical News, January 26, 2023
• 'Clinical Paradox'? Bariatric Surgery May Protect From GI Cancers In a large French study, bariatric surgery was associated with a significant reduction in incidence of esophageal and gastric cancer as well as overall mortality.
  Medscape Medical News, January 12, 2023
• PPI Use in Type 2 Diabetes Links With Cardiovascular Events Prospective data from almost 20,000 people with type 2 diabetes show that proton pump inhibitor use is linked with significantly more cardiovascular disease events and all-cause death than nonuse.
  Medscape Medical News, January 10, 2023
• Expert Panel Forms Strategy for EoE Monitoring Regular follow-up can reduce the risk of recurrence, esophageal remodeling, fibrosis, and stricture.
  Medscape Medical News, January 09, 2023
• Obesity Impacts Peripheral Airway Reactivity, Asthma Obese individuals with asthma and obese controls showed similar changes in response to methacholine.
  Medscape Medical News, January 09, 2023
• Comorbidities and the Prognosis of COPD At a recent conference, experts discussed the benefits that strict control of comorbidities can have for patients with chronic obstructive pulmonary disease.
  Medscape Medical News, January 03, 2023
• Study Evaluates Alopecia Areata Features in Hispanic Population In the study, the most common comorbidity in patients overall was atopy, including allergic rhinitis, asthma, and/or atopic dermatitis.
  MDedge News, December 29, 2022
• Dupilumab Effective for Eosinophilic Esophagitis Up to 52 Weeks The new biologic will most likely be used in patients refractory to proton pump inhibitors and topical steroids.
  Medscape Medical News, December 28, 2022
• Alert FDA Expands Approval of Imaging Agent Cytalux for Lung Cancer The expanded indication for pafolacianine (Cytalux) follows an initial approval in November 2021 for use in patients with ovarian cancer.
  Medscape Medical News, December 19, 2022
• High Rates of Inappropriate PPI Use in Hospitalized Patients More than two fifths of patients discharged with a proton pump inhibitor prescription may have been given it inappropriately, say Israeli researchers who call for action to improve the problem.
  Medscape Medical News, December 07, 2022